HealthCor Management L.P. acquired a new position in Hill-Rom Holdings, Inc. (NYSE:HRC) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 807,760 shares of the medical technology company’s stock, valued at approximately $76,253,000. Hill-Rom accounts for about 2.5% of HealthCor Management L.P.’s portfolio, making the stock its 19th largest holding. HealthCor Management L.P. owned about 1.22% of Hill-Rom at the end of the most recent quarter.
Other institutional investors have also recently modified their holdings of the company. Oakbrook Investments LLC raised its position in shares of Hill-Rom by 34.5% in the third quarter. Oakbrook Investments LLC now owns 8,967 shares of the medical technology company’s stock worth $846,000 after acquiring an additional 2,300 shares during the period. Marshall Wace LLP acquired a new position in shares of Hill-Rom in the second quarter worth about $10,392,000. Millennium Management LLC raised its position in shares of Hill-Rom by 32.3% in the second quarter. Millennium Management LLC now owns 583,635 shares of the medical technology company’s stock worth $50,975,000 after acquiring an additional 142,654 shares during the period. State of Alaska Department of Revenue raised its position in shares of Hill-Rom by 14.5% in the third quarter. State of Alaska Department of Revenue now owns 7,674 shares of the medical technology company’s stock worth $724,000 after acquiring an additional 974 shares during the period. Finally, Valeo Financial Advisors LLC raised its position in shares of Hill-Rom by 18,894.9% in the third quarter. Valeo Financial Advisors LLC now owns 95,924 shares of the medical technology company’s stock worth $8,065,000 after acquiring an additional 95,419 shares during the period. Institutional investors and hedge funds own 82.57% of the company’s stock.
In related news, SVP Andreas G. Frank sold 7,454 shares of the company’s stock in a transaction dated Wednesday, November 28th. The shares were sold at an average price of $95.76, for a total transaction of $713,795.04. Following the completion of the sale, the senior vice president now owns 27,224 shares of the company’s stock, valued at approximately $2,606,970.24. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 1.90% of the stock is currently owned by corporate insiders.
HRC has been the subject of a number of analyst reports. ValuEngine downgraded shares of Hill-Rom from a “buy” rating to a “hold” rating in a research report on Thursday, October 4th. Raymond James upped their price target on shares of Hill-Rom from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Monday, November 5th. Barclays started coverage on shares of Hill-Rom in a research report on Monday, October 15th. They set an “equal weight” rating and a $95.00 price target for the company. Morgan Stanley upped their price target on shares of Hill-Rom from $95.00 to $100.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 11th. Finally, Zacks Investment Research downgraded shares of Hill-Rom from a “buy” rating to a “hold” rating in a research report on Wednesday, November 14th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $103.67.
HRC opened at $92.59 on Friday. Hill-Rom Holdings, Inc. has a twelve month low of $78.16 and a twelve month high of $99.81. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.74 and a quick ratio of 1.30. The stock has a market cap of $6.23 billion, a P/E ratio of 19.49, a P/E/G ratio of 1.29 and a beta of 0.94.
Hill-Rom (NYSE:HRC) last released its quarterly earnings results on Friday, November 2nd. The medical technology company reported $1.63 earnings per share for the quarter, topping the consensus estimate of $1.51 by $0.12. Hill-Rom had a net margin of 8.86% and a return on equity of 21.10%. The firm had revenue of $759.20 million during the quarter, compared to the consensus estimate of $750.90 million. During the same quarter in the prior year, the firm earned $1.32 EPS. The company’s revenue for the quarter was up 2.8% on a year-over-year basis. On average, sell-side analysts expect that Hill-Rom Holdings, Inc. will post 5.13 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Monday, December 31st. Investors of record on Friday, December 14th will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Thursday, December 13th. This represents a $0.80 annualized dividend and a dividend yield of 0.86%. Hill-Rom’s dividend payout ratio (DPR) is presently 16.84%.
COPYRIGHT VIOLATION NOTICE: “HealthCor Management L.P. Invests $76.25 Million in Hill-Rom Holdings, Inc. (HRC) Stock” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this report can be read at https://www.dispatchtribunal.com/2018/12/16/healthcor-management-l-p-invests-76-25-million-in-hill-rom-holdings-inc-hrc-stock.html.
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Read More: What is the float in trading stocks?
Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.